Incruse Ellipta

Umeclidinium Bromide

4.9 Moderate risk

Incruse Ellipta & Wrong technique in device usage process

13.0%

of users reported Wrong technique in device usage process

77.8%

also reported Severe reaction

65.2%

are women

Most common medical consequences

Severe reaction

77.8%

Hospitalization

22.2%

Have you experienced any negative side effects from this medication?

Incruse Ellipta: general information

Most common side effects (86)

Most commonly affected ages

50 - 59 years

10.8%

60 - 69 years

29.8%

70 - 79 years

39.3%

80 - 89 years

18.5%

90 - 99 years

1.6%

On this page